Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K I Kaitin

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Psychopharmacology|January 1, 1985
Effects of thalidomide and pentobarbital on neuronal activity in the preoptic area during sleep and wakefulness in the catK I Kaitin
Law, Medicine & Health Care : a Publication of the American Society of Law & Medicine|January 1, 1991
Case studies of expedited review: AZT and L-dopaK I Kaitin
American Journal of Therapeutics|May 1, 1997
The prescription Drug User Fee Act of 1992 and the new drug development processK I Kaitin
Clinical Pharmacology and Therapeutics|January 19, 2008
Obstacles and opportunities in new drug developmentK I Kaitin
Clinical Pharmacology and Therapeutics|February 5, 2010
Deconstructing the drug development process: the new face of innovationK I Kaitin
The New England Journal of Medicine|August 1, 1991
Graft-versus-host diseaseK I Kaitin
Experimental Neurology|February 1, 1984
Preoptic area unit activity during sleep and wakefulness in the catK I Kaitin
Clinical Pharmacology and Therapeutics|August 1, 1989
Reply to "Understanding Comparisons of Drug Introductions Between the United States and the United Kingdom"K I Kaitin
American Journal of Therapeutics|January 1, 1997
The new drug approvals of 1993, 1994, and 1995: trends in drug developmentK I Kaitin, M Manocchia
Science (New York, N.Y.)|December 29, 1998
Issues facing the new FDA commissionerL Lasagna, K I Kaitin
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Psychopharmacology|January 1, 1985
Effects of thalidomide and pentobarbital on neuronal activity in the preoptic area during sleep and wakefulness in the catK I Kaitin
Law, Medicine & Health Care : a Publication of the American Society of Law & Medicine|January 1, 1991
Case studies of expedited review: AZT and L-dopaK I Kaitin
American Journal of Therapeutics|May 1, 1997
The prescription Drug User Fee Act of 1992 and the new drug development processK I Kaitin
Clinical Pharmacology and Therapeutics|January 19, 2008
Obstacles and opportunities in new drug developmentK I Kaitin
Clinical Pharmacology and Therapeutics|February 5, 2010
Deconstructing the drug development process: the new face of innovationK I Kaitin
The New England Journal of Medicine|August 1, 1991
Graft-versus-host diseaseK I Kaitin
Experimental Neurology|February 1, 1984
Preoptic area unit activity during sleep and wakefulness in the catK I Kaitin
Clinical Pharmacology and Therapeutics|August 1, 1989
Reply to "Understanding Comparisons of Drug Introductions Between the United States and the United Kingdom"K I Kaitin
American Journal of Therapeutics|January 1, 1997
The new drug approvals of 1993, 1994, and 1995: trends in drug developmentK I Kaitin, M Manocchia
Science (New York, N.Y.)|December 29, 1998
Issues facing the new FDA commissionerL Lasagna, K I Kaitin
Pageof 4